Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth

Francisco Verdeguer1, Claudia Castro, Markus Kubicek

  • 1Laboratory of Vascular Biology, Department of Molecular and Cellular Pathology and Therapy, Instituto de Biomedicina de Valencia (IBV-CSIC), Spanish Council for Scientific Research, 46010 Valencia, Spain.

Insights

Hypercholesterolemia activates complement components (CCs), particularly C3 and C3a. This activation promotes vascular smooth muscle cell and macrophage proliferation, potentially contributing to atherosclerosis development.

Area of Science:

  • Immunology
  • Cardiovascular Biology

Background:

  • Atherosclerosis is linked to complement system activation.
  • Hypercholesterolemia is a major risk factor for atherosclerosis.

Purpose of the Study:

  • Investigate complement component (CC) expression in hypercholesterolemia.
  • Determine the effects of CCs on vascular smooth muscle cell (VSMC) and macrophage proliferation.
  • Elucidate the molecular mechanisms of CC-mediated proliferation.

Main Methods:

  • Analyzed mRNA and protein expression of CCs in hypercholesterolemic mice (apoE-KO) and human plasma (familial hypercholesterolemia patients).
  • Conducted in vitro studies on VSMC and macrophage proliferation.
  • Assessed CCs' role in proliferation via Gi protein-dependent ERK1/2 activation.

Main Results:

  • Hypercholesterolemic apoE-KO mice and FH patients showed elevated CCs (C3, C4, C1s, C1q).
  • C3 and C3a, but not other CCs, promoted VSMC and macrophage proliferation.
  • C3/C3a mediated proliferation via Gi protein-dependent ERK1/2 activation.

Conclusions:

  • Hypercholesterolemia triggers coordinated CC activation.
  • C3/C3a drive VSMC and macrophage proliferation, suggesting a role in atheroma growth.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Inflammation01:38

Inflammation

Overview
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...